Transformative Trends Impacting the Mechanical Circulatory Support Devices Market Landscape: Innovations In Mechanical Circulatory Support Devices Enhance Patient Outcomes

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Mechanical Circulatory Support Devices Market Size By 2025?
In recent times, the market size for mechanical circulatory support devices has seen a significant surge. It is projected to grow from a size of $3.14 billion in 2024, reaching a worth of $3.47 billion in 2025, with a compound annual growth rate (CAGR) of 10.4%. The historic growth trend can be credited to factors such as an increase in end-stage heart failure cases, improved post-surgery survival rates, a rise in bridge-to-transplant procedures, enhanced awareness amongst cardiologists, and an expanding global elderly population.

How Big Is the Mechanical Circulatory Support Devices Market Size Expected to Grow by 2029?
In the upcoming years, a swift expansion is anticipated in the market size of mechanical circulatory support devices. Projected to soar to a worth of $5.08 billion by 2029, this market will experience a compound annual growth rate (CAGR) of 10.0%. Factors contributing to this promising growth during the forecast period include the escalating occurrence of cardiovascular diseases, the rising acceptance of destination therapy, increasing global healthcare spending, an uptick in clinical trials for next-generation devices, beneficial regulations, and a deficit of heart donors for transplants. Significant trends expected during this period include the innovation of fully implantable Ventricular Assist Device (VAD) systems, the amalgamation of smart sensors in devices, the implementation of artificial intelligence for patient monitoring, improvements in magnetically levitated pumps, and the introduction of biocompatible polymers and coatings.

View the full report here:
https://www.thebusinessresearchcompany.com/report/mechanical-circulatory-support-devices-global-market-report

Which Key Market Drivers Powering Mechanical Circulatory Support Devices Market Expansion and Growth?
The mechanical circulatory support devices market is projected to expand due to the increasing rates of heart failure. Heart failure, a chronic condition that stops the heart from efficiently circulating blood through the body, is becoming more prevalent largely due to the aging population. As individuals age, they are more susceptible to cardiovascular diseases and associated complications. The function of mechanical circulatory support devices is to aid heart functionality by enhancing blood circulation and reducing the strain on a weakened heart. For example, the Heart Failure Society of America (HFSA), a US-based non-profit organization, reported in September 2024 that heart failure currently affects 6.7 million Americans over 20 years old. Predictions state that by 2030 this will increase to 8.7 million, by 2040 to 10.3 million, and 11.4 million by 2050. As a result, the escalating rates of heart failure pave the way for growth in the mechanical circulatory support devices market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27334&type=smp

What Are the Key Trends Driving Mechanical Circulatory Support Devices Market Growth?
Key players in the mechanical circulatory support devices market are concentrating their efforts on creating innovative technologies, including magnetically levitated rotor (MAGLEV) technology, with the aim of providing more dependable and effective devices for patients. These devices are designed to improve heart functionality and boost survival rates. The use of magnetically levitated rotor (MAGLEV) technology involves the use of magnetic fields to suspend and revolve a rotor without physical interaction, thereby minimizing friction and wear leading to a more durable and efficient device performance. For instance, in July 2024, the US-based medical device firm, BiVACOR Inc., embarked on the first-in-human implantation of their Total Artificial Heart (TAH). This novel device is engineered to entirely substitute the two ventricles of a failing heart in patients suffering from severe biventricular or univentricular heart failure who are not suitable candidates for traditional left ventricular assist devices. It attempts to provide a critical bridge-to-transplant solution with the potential to enhance lifespan and life quality for numerous patients who have few treatment options due to the lack of available donor hearts.

What Are the Emerging Segments in the Mechanical Circulatory Support Devices Market?
The mechanical circulatory support devices market covered in this report is segmented

1) By Type: Intra-Aortic Balloon Pump, Ventricular Assist Device, Total Artificial Heart, Extracorporeal Membrane Oxygenation
2) By Technology: Pulsatile Flow Devices, Non-Pulsatile Flow Devices
3) By Application: Cardiac Surgery, Heart Failure Management, Myocardial Infraction, Cardiogenic Shock
4) By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other Healthcare Facilities

Subsegments:
1) By Intra-Aortic Balloon Pump: Percutaneous Intra-Aortic Balloon Pump, Surgical Intra-Aortic Balloon Pump
2) By Ventricular Assist Device: Left Ventricular Assist Device, Right Ventricular Assist Device, Biventricular Assist Device
3) By Total Artificial Heart: Pneumatic Total Artificial Heart, Electric Total Artificial Heart
4) By Extracorporeal Membrane Oxygenation: Venoarterial Extracorporeal Membrane Oxygenation, Venovenous Extracorporeal Membrane Oxygenation

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=27334&type=smp

Who Are the Global Leaders in the Mechanical Circulatory Support Devices Market?
Major companies operating in the mechanical circulatory support devices market are Johnson & Johnson, Abbott Laboratories, Medtronic Plc, Fresenius Medical Care AG & Co. KGaA, Boston Scientific Corporation, Terumo Corporation, Teleflex Incorporated, Getinge AB, LivaNova PLC, Supira Medical Inc., BrioHealth Solutions Inc., Magenta Medical Ltd., CorWave SA, Jarvik Heart Inc., Carmat SAS, Procyrion Inc., BiVACOR Inc., CardioBridge GmbH, Evaheart Inc., and ReliantHeart Inc.

Which are the Top Profitable Regional Markets for the Mechanical Circulatory Support Devices Industry?
North America was the largest region in the mechanical circulatory support devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mechanical circulatory support devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=27334

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.